Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease. Melanson M, Nalbantoglu J, Berkovic S, Melmed C, Andermann E, Roberts LJ, Carpenter S, Snipes GJ, Andermann F (1997) Neurology 49: 1732-3 Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice. Mistry AM, Thompson CH, Miller AR, Vanoye CG, George AL, Kearney JA (2014) Neurobiol Dis 65: 1-11 Impaired surface αβγ GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation. Tian M, Mei D, Freri E, Hernandez CC, Granata T, Shen W, Macdonald RL, Guerrini R (2013) Neurobiol Dis 50: 135-41 The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through. Huang X, Tian M, Hernandez CC, Hu N, Macdonald RL (2012) Neurobiol Dis 48: 115-23 Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome. Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA (2017) Epilepsia 58: e111-e115 Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2 Dravet syndrome mice. Huang X, Zhou C, Tian M, Kang JQ, Shen W, Verdier K, Pimenta A, MacDonald RL (2017) Epilepsia 58: 1451-1461 The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model. Hawkins NA, Lewis M, Hammond RS, Doherty JJ, Kearney JA (2017) Sci Rep 7: 15327 Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome. Anderson LL, Hawkins NA, Thompson CH, Kearney JA, George AL (2017) Sci Rep 7: 1682 Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Ma S, Blair MA, Abou-Khalil B, Lagrange AH, Gurnett CA, Hedera P (2006) Epilepsy Res 71: 129-34
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.